PAPER Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, Liu J, Ye H, Shen Y, Li Y, Rao EJ, Fushimi K, Zhou X, Bigio EH, Mesulam M, Xu Q, Wu JY
SEARCH RESULTS
330913 RESULTS
PAPER Yagi T, Ito D, Nihei Y, Ishihara T, Suzuki N
N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress.
Hum Mol Genet. 2011 Oct 1;20(19):3831-40. PubMed: 21750110PAPER Ugland H, Naderi S, Brech A, Collas P, Blomhoff HK
cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1.
Autophagy. 2011 Oct;7(10):1199-211. PubMed: 21750416PAPER Hao Y, Perkinton MS, Chan WW, Chan HY, Miller CC, Lau KF
GULP1 is a novel APP-interacting protein that alters APP processing.
Biochem J. 2011 Aug 1;437(3):576. PubMed: 21749325PAPER Davidsson J, Risling M
A new model to produce sagittal plane rotational induced diffuse axonal injuries.
Front Neurol. 2011;2:41. PubMed: 21747777PAPER Viana RJ, Steer CJ, Rodrigues CM
Amyloid-β peptide-induced secretion of endoplasmic reticulum chaperone glycoprotein GRP94.
J Alzheimers Dis. 2011 Jan 1;27(1):61-73. PubMed: 21750376PAPER Burns JM, Honea RA, Vidoni ED, Hutfles L, Brooks WM, Swerdlow RH
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging.
Biochim Biophys Acta. 2011 Jul 1; PubMed: 21745566PAPER Cantin S, Villien M, Moreaud O, Tropres I, Keignart S, Chipon E, Le Bas JF, Warnking J, Krainik A
Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI.
Neuroimage. 2011 Sep 15;58(2):579-87. PubMed: 21745581PAPER Saxena S, Caroni P
Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
Neuron. 2011 Jul 14;71(1):35-48. PubMed: 21745636PAPER Tang JX, Mardini F, Caltagarone BM, Garrity ST, Li RQ, Bianchi SL, Gomes O, Laferla FM, Eckenhoff RG, Eckenhoff MF
Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model.
Alzheimers Dement. 2011 Sep;7(5):521-531.e1. PubMed: 21745760PAPER Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B
Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.
Alzheimers Dement. 2011 Nov;7(6):602-610.e2. Epub 2011 Jul 13 PubMed: 21745761PAPER Mossello E, Ballini E, Boncinelli M, Monami M, Lonetto G, Mello AM, Tarantini F, Baldasseroni S, Mannucci E, Marchionni N
Glucagon-like peptide-1, diabetes, and cognitive decline: possible pathophysiological links and therapeutic opportunities.
Exp Diabetes Res. 2011;2011:281674. PubMed: 21747826PAPER Yao J, Chen S, Mao Z, Cadenas E, Brinton RD
2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
PLoS One. 2011;6(7):e21788. PubMed: 21747957PAPER Dai L, Liu D, Guo H, Wang Y, Bai Y
Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.
J Neurol. 2011 Jul 12; PubMed: 21748280PAPER Neugroschl J, Wang S
Alzheimer's disease: diagnosis and treatment across the spectrum of disease severity.
Mt Sinai J Med. 2011 Jul-Aug;78(4):596-612. PubMed: 21748748Current Filters
No filters selected